维普中文期刊产品整合服务
16篇 您的检索式:作者名="Delagrange D"
    题名 作者 年代 出处 被引量
1Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end points 显示文摘Kinaly S Selwyn AP Delagrange D 1996Curr Opin Lipidol1996,7,:1
2Biological mechanismsf or the clinical success of lipid-low ering in coronary artery disease and the use of surrogate end points 显示文摘Kinlay S Selwyn AP Delagrange D 1996Curr Opin Lipidol1996,,7:1
3Thermal bremsstrahlung photons probing the nuclear caloric curve显示文摘D.G. d’Enterria G. Martínez L. Aphecetche H. Delagrange F. Fernández H. L?hner R. Ortega R. Ostendorf Y. Schutz H.W. Wilschut 2002Physics Letters B2002,,1:1
4Biological mechanisms for the clinical success of lipid - lowering in coronary artery disease and the use of surrogate end points 显示文摘 Selwyn AP Delagrange D 1996Curr Opin Lipidol1996,7,:1
5Biological mechanisms for the clinical success of lipidlowering in coronary artery disease and the use of surrogate endpoints 显示文摘Kinlay S Selwyn AP Delagrange D 1996Curr Opin Lipidol1996,7,:1
6Biological mechanisms for the clinical success of lipid lowering in coronary artery disease and the use of surrogate and points显示文摘Kinlay S Selwyn AP Delagrange D 1996Cur Opin Lipidol1996,7,:1
7Close relation of endothelial function in the human coronary and peripheral circulations 显示文摘Anderson T J Uehata A Gerhard M D Meredith I T Knab S Delagrange D 1995J Am Coll Car- diol1995,26,:1
8Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end points显示文摘Kinlay S Selwyn AP Delagrange D 1996Curr Opin Lipidol1996,7,:1
9Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points 显示文摘Kinlay S Selwyn AP Delagrange D 1996Curr Opin Lipidol1996,7,6:1
10显示文摘Delagrange A D 1983EDN1983,28,13:1
11Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use ofsurrogate end points 显示文摘KINLAY S SELWYN A P DELAGRANGE D 1996Curr Opin Lipidol1996,7,:1
12Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points显示文摘 Selwyn AP Delagrange D 1996Curr Opin Lipidol1996,7,:1
13Biological mecha- nisms for the clinical success of lipid lowering in coronary ar- tery disease and the use of surrogate end points显示文摘Kinlay S Selwyn AP Delagrange D 1996Curr Opin Lipidol1996,7,:1
14Biological mechanisms for the clinical success of hpid-lowering in coronary artery disease and the use of surrogate end points 显示文摘Kinlay S Selwyn AP Delagrange D 1996Curr Opin Lipidol1996,7,:1
15Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points显示文摘Kinlay S Selwyn AP Delagrange D el al 1996Curr Opin Lipidol1996,7,6:1
16Biological mechanisms for the clinical success of lipida loweing in coronary artery disease and the use of sunogate endzpoints显示文摘Kinlay S Selwyn AP Delagrange D 1996Cunopinlipido1996,,7:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费